Home The Word Brain	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Ear2Memory – Free App | Free PDF | Web Learning languages on your smartphone By BSK	Free Abstracts

Leukemia

Free Subscription 28.08.2017 1 Am J Hematol 5 Ann Hematol 9 Blood 1 BMC Genomics 2 Cancer 1 Cancer Chemother Pharmacol 1 Cancer Lett 1 Cell 1 Eur J Haematol 2 Int J Hematol 1 J Clin Oncol 4 Leuk Lymphoma 3 Leuk Res 4 Leukemia 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Hematol

1. SHI CR, Nambudiri VE
   Imatinib-induced psoriasiform eruption in a patient with chronic myeloid leukemia.
   Am J Hematol. 2017 Aug 24. doi: 10.1002/ajh.24894.
   PubMed     Text format    
   
   

   
   Ann Hematol

2. LOU Y, Ma Y, Sun J, Suo S, et al
   Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia.
   Ann Hematol. 2017 Aug 19. doi: 10.1007/s00277-017-3096.
   PubMed     Text format     Abstract available
   
   
3. SHAO H, Yang Q, Wu C, Cen J, et al
   Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21).
   Ann Hematol. 2017 Aug 24. doi: 10.1007/s00277-017-3110.
   PubMed     Text format    
   
   
4. OH SB, Park SW, Chung JS, Lee WS, et al
   Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy.
   Ann Hematol. 2017 Aug 21. doi: 10.1007/s00277-017-3104.
   PubMed     Text format     Abstract available
   
   
5. IURLO A, Bucelli C, Cattaneo D, Orofino N, et al
   Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia.
   Ann Hematol. 2017 Aug 19. doi: 10.1007/s00277-017-3105.
   PubMed     Text format    
   
   
6. CHOI DC, Tremblay D, Iancu-Rubin C, Mascarenhas J, et al
   Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms.
   Ann Hematol. 2017;96:919-927.
   PubMed     Text format     Abstract available
   
   

   
   Blood

7. GO RS, Winters JL, Kay NE
   How I treat autoimmune hemolytic anemia.
   Blood. 2017 Mar 30. pii: blood-2016-11-693689. doi: 10.1182/blood-2016-11-693689
   PubMed     Text format     Abstract available
   
   
8. FRISMANTAS V, Dobay MP, Rinaldi A, Tchinda J, et al
   Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia.
   Blood. 2017;129:e26-e37.
   PubMed     Text format     Abstract available
   
   
9. ANGUILLE S, Van de Velde AL, Smits EL, Van Tendeloo VF, et al
   Dendritic cell vaccination as post-remission treatment to prevent or delay relapse in acute myeloid leukemia.
   Blood. 2017 Aug 22. pii: blood-2017-04-780155. doi: 10.1182/blood-2017-04-780155
   PubMed     Text format     Abstract available
   
   
10. WALLACE JA, Kagele DA, Eiring AM, Kim CN, et al
    miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response.
    Blood. 2017;129:3074-3086.
    PubMed     Text format     Abstract available
    
    
11. ZHOU XY, Behdad A
    Relapse of an acute leukemia of mixed lineage as an isolated orbital mass.
    Blood. 2017;130:953.
    PubMed     Text format    
    
    
12. KORN C, Mendez-Ferrer S
    Myeloid malignancies and the microenvironment.
    Blood. 2017;129:811-822.
    PubMed     Text format     Abstract available
    
    
13. BRUNSON A, Keegan THM, Bang H, Mahajan A, et al
    Increased risk of leukemia among sickle cell disease patients in California.
    Blood. 2017 Aug 22. pii: blood-2017-05-783233. doi: 10.1182/blood-2017-05-783233
    PubMed     Text format    
    
    
14. DOVEY OM, Cooper JL, Mupo A, Grove CS, et al
    Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.
    Blood. 2017 Aug 23. pii: blood-2017-01-760595. doi: 10.1182/blood-2017-01-760595
    PubMed     Text format     Abstract available
    
    
15. GIRARDI T, Vicente C, Cools J, De Keersmaecker K, et al
    The genetics and molecular biology of T-ALL.
    Blood. 2017;129:1113-1123.
    PubMed     Text format     Abstract available
    
    

    
    BMC Genomics

16. KUMAR A, Kankainen M, Parsons A, Kallioniemi O, et al
    The impact of RNA sequence library construction protocols on transcriptomic profiling of leukemia.
    BMC Genomics. 2017;18:629.
    PubMed     Text format     Abstract available
    
    

    
    Cancer

17. PRINTZ C
    First person: Rudiger Hehlmann: The professor of medicine and founder of the European LeukemiaNet builds on his hard-won legacy of improving the survival rates of patients with leukemia.
    Cancer. 2017;123:3209-3210.
    PubMed     Text format    
    
    
18. MANYAM BV, Garsa AA, Chin RI, Reddy CA, et al
    A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Cancer. 2017 Feb 7. doi: 10.1002/cncr.30601.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Chemother Pharmacol

19. BEN HASSINE I, Gharbi H, Soltani I, Ben Hadj Othman H, et al
    Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia.
    Cancer Chemother Pharmacol. 2017 Aug 23. doi: 10.1007/s00280-017-3424.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

20. PRIGOZHINA TB, Szafer F, Aronin A, Tzdaka K, et al
    Fn14.TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog.
    Cancer Lett. 2017;400:99-109.
    PubMed     Text format     Abstract available
    
    

    
    Cell

21. CIMMINO L, Dolgalev I, Wang Y, Yoshimi A, et al
    Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
    Cell. 2017 Aug 16. pii: S0092-8674(17)30868-1. doi: 10.1016/j.cell.2017.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Haematol

22. ISHIKAWA C, Senba M, Hashimoto T, Imaizumi A, et al
    Expression and significance of Pim-3 kinase in adult T-cell leukemia.
    Eur J Haematol. 2017 Aug 19. doi: 10.1111/ejh.12940.
    PubMed     Text format     Abstract available
    
    

    
    Int J Hematol

23. KOTAKI R, Higuchi H, Ogiya D, Katahira Y, et al
    Imbalanced expression of polycistronic miRNA in acute myeloid leukemia.
    Int J Hematol. 2017 Aug 22. doi: 10.1007/s12185-017-2314.
    PubMed     Text format     Abstract available
    
    
24. HAN DM, Zheng XL, Ding L, Yan HM, et al
    Risk factors in patients undergoing haploidentical hematopoietic stem cell transplantation for high-risk childhood acute leukemia.
    Int J Hematol. 2017 Aug 20. doi: 10.1007/s12185-017-2317.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

25. KROGER N, Iacobelli S, Franke GN, Platzbecker U, et al
    Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial).
    J Clin Oncol. 2017;35:2157-2164.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Lymphoma

26. SI T, Lu Y, Li F, Jiang L, et al
    High expression of INHBA is an adverse prognostic factor for de novo acute myeloid leukemia.
    Leuk Lymphoma. 2017 Aug 24:1-7. doi: 10.1080/10428194.2017.1324157.
    PubMed     Text format     Abstract available
    
    
27. IACCARINO L, Ottone T, Hasan SK, Divona M, et al
    Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
    Leuk Lymphoma. 2017 Aug 24:1-3. doi: 10.1080/10428194.2017.1369067.
    PubMed     Text format    
    
    
28. FALANTES J, Pleyer L, Thepot S, Almeida AM, et al
    Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).
    Leuk Lymphoma. 2017 Aug 24:1-8. doi: 10.1080/10428194.2017.1365854.
    PubMed     Text format     Abstract available
    
    
29. BODDU P, Kantarjian H, Garcia-Manero G, Ravandi F, et al
    Time to response and survival in hypomethylating agent-treated acute myeloid leukemia.
    Leuk Lymphoma. 2017 Aug 25:1-4. doi: 10.1080/10428194.2017.1365857.
    PubMed     Text format    
    
    

    
    Leuk Res

30. YAO C, Zhang G, Walker A, Zhao KY, et al
    Potent induction of apoptosis by givinostat in BCR-ABL1-positive and BCR-ABL1-negative precursor B-cell acute lymphoblastic leukemia cell lines.
    Leuk Res. 2017;60:129-134.
    PubMed     Text format     Abstract available
    
    
31. VAVROVA E, Kantorova B, Vonkova B, Kabathova J, et al
    Fragment analysis represents a suitable approach for the detection of hotspot c.7541_7542delCT NOTCH1 mutation in chronic lymphocytic leukemia.
    Leuk Res. 2017;60:145-150.
    PubMed     Text format     Abstract available
    
    
32. CAOCCI G, Greco M, Arras M, Cusano R, et al
    HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia.
    Leuk Res. 2017;61:1-5.
    PubMed     Text format     Abstract available
    
    

    
    Leukemia

33. PENA-MARTINEZ P, Eriksson M, Ramakrishnan R, Chapellier M, et al
    Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6 dependent manner.
    Leukemia. 2017 Aug 18. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available
    
    
34. TOFT N, Birgens H, Abrahamsson J, Griskevicius L, et al
    Results of NOPHO ALL2008 treatment for patients 1-45 years with acute lymphoblastic leukemia.
    Leukemia. 2017 Aug 18. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available
    
    
35. ZHAO L, Alkadi H, Kwon EM, Zhen T, et al
    The C-terminal multimerization domain is essential for leukemia development by CBFbeta-SMMHC in a mouse knockin model.
    Leukemia. 2017 Aug 18. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available
    
    
36. JYOTSANA N, Sharma A, Chaturvedi A, Scherr M, et al
    RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo.
    Leukemia. 2017 Aug 22. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

37. MITSUHASHI Y, Furusawa Y, Aradate T, Zhao QL, et al
    3-O-trans-p-coumaroyl-alphitolic acid, a triterpenoid from Zizyphus jujuba, leads to apoptotic cell death in human leukemia cells through reactive oxygen species production and activation of the unfolded protein response.
    PLoS One. 2017;12:e0183712.
    PubMed     Text format     Abstract available
    
    
38. SETHI MK, Thol F, Stadler M, Heuser M, et al
    VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation.
    PLoS One. 2017;12:e0168096.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: